Welcome to our two-episode series: MD3D: Metabolic dysfunction-associated steatohepatitis — The Role of Primary Care providers in the Growing Epidemic. 

These episodes have been developed in partnership between American Gastroenterological Association (AGA) and Projects In Knowledge (PIK) Powered By Kaplan and are featured on both AGA’s Inside Scope podcast as well as PIK’s Morning Commute podcast. 

In episode two, “MASH: How to Treat and When to Refer,” Drs. Arun Sanyal and Mary Rinella take a look at the role that primary care physicians can play in the treatment of MASH, how can they treat and monitor these patients, and most importantly, when should a specialist be called in. 

Our experts will review current treatment guidelines and care pathways for MASH. They’ll discuss the role of PCPs in the multidisciplinary management of patients with MASH, including the referral of high-risk patients to specialists. Finally, they’ll share the management of underlying metabolic conditions, such as T2DM and obesity, in patients with MASH who are at low risk of fibrosis. 

This program is supported by an educational grant from Novo Nordisk. Information about the faculty and disclosures can be found by visiting : https://suitehome.atpointofcare.com/library/2711.02/page/0?subdomain=mash. You can also use this link to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

Welcome to our two-episode series: MD3D: Metabolic dysfunction-associated steatohepatitis — The Role of Primary Care providers in the Growing Epidemic. These episodes have been developed in partnership between American Gastroenterological Association (AGA) and Projects In Knowledge (PIK) Powered By Kaplan and are featured on both AGA’s Inside Scope podcast as well as PIK’s Morning Commute podcast. In episode two, “MASH: How to Treat and When to Refer,” Drs. Arun Sanyal and Mary Rinella take a look at the role that primary care physicians can play in the treatment of MASH, how can they treat and monitor these patients, and most importantly, when should a specialist be called in. Our experts will review current treatment guidelines and care pathways for MASH. They’ll discuss the role of PCPs in the multidisciplinary management of patients with MASH, including the referral of high-risk patients to specialists. Finally, they’ll share the management of underlying metabolic conditions, such as T2DM and obesity, in patients with MASH who are at low risk of fibrosis. This program is supported by an educational grant from Novo Nordisk. Information about the faculty and disclosures can be found by visiting : https://suitehome.atpointofcare.com/library/2711.02/page/0?subdomain=mash. You can also use this link to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

MASH: How to Treat and When to Refer

Lee Kaplan, MD, founding director of the Weight Center at Massachusetts General Hospital, discusses the relationship between NASH, obesity and associated comorbidities. 

This is episode 2 of our 6-part podcast, NASH: Take Action!, where leaders in gastroenterology, hepatology, endocrinology and primary care discuss the real-world, practical implications of screening, diagnosing and managing people with NAFLD and NASH. This series is hosted by Drs. Fasiha Kanwal, Kenneth Cusi and Jay H. Shubrook. 

To collect CME credit for listening, visit nash.gastro.org.

Lee Kaplan, MD, founding director of the Weight Center at Massachusetts General Hospital, discusses the relationship between NASH, obesity and associated comorbidities. This is episode 2 of our 6-part podcast, NASH: Take Action!, where leaders in gastroenterology, hepatology, endocrinology and primary care discuss the real-world, practical implications of screening, diagnosing and managing people with NAFLD and NASH. This series is hosted by Drs. Fasiha Kanwal, Kenneth Cusi and Jay H. Shubrook. To collect CME credit for listening, visit nash.gastro.org.

NASH: Metabolic syndrome

Kim Pfotenhauer, DO, Michigan State University, and Eugene Wright, MD, Duke University, discuss screening people for NAFLD in the primary care setting.

This is episode 3 of our 6-part podcast, NASH: Take Action!, where leaders in gastroenterology, hepatology, endocrinology and primary care discuss the real-world, practical implications of screening, diagnosing and managing people with NAFLD and NASH. This series is hosted by Drs. Fasiha Kanwal, Kenneth Cusi and Jay H. Shubrook. 

To collect CME credit for listening, visit nash.gastro.org.

Kim Pfotenhauer, DO, Michigan State University, and Eugene Wright, MD, Duke University, discuss screening people for NAFLD in the primary care setting. This is episode 3 of our 6-part podcast, NASH: Take Action!, where leaders in gastroenterology, hepatology, endocrinology and primary care discuss the real-world, practical implications of screening, diagnosing and managing people with NAFLD and NASH. This series is hosted by Drs. Fasiha Kanwal, Kenneth Cusi and Jay H. Shubrook. To collect CME credit for listening, visit nash.gastro.org.

NASH: Screening in the primary care setting

Vincent Wong, MD, The Chinese University of Hong Kong, provides insights into noninvasive diagnostic techniques for patients at high risk for NASH and the role of liver biopsy in diagnosing NASH.

This is episode 4 of our 6-part podcast, NASH: Take Action!, where leaders in gastroenterology, hepatology, endocrinology and primary care discuss the real-world, practical implications of screening, diagnosing and managing people with NAFLD and NASH. This series is hosted by Drs. Fasiha Kanwal, Kenneth Cusi and Jay H. Shubrook. 

To collect CME credit for listening, visit nash.gastro.org.

Vincent Wong, MD, The Chinese University of Hong Kong, provides insights into noninvasive diagnostic techniques for patients at high risk for NASH and the role of liver biopsy in diagnosing NASH. This is episode 4 of our 6-part podcast, NASH: Take Action!, where leaders in gastroenterology, hepatology, endocrinology and primary care discuss the real-world, practical implications of screening, diagnosing and managing people with NAFLD and NASH. This series is hosted by Drs. Fasiha Kanwal, Kenneth Cusi and Jay H. Shubrook. To collect CME credit for listening, visit nash.gastro.org.

NASH: Diagnosing NAFLD and NASH

The NASH: Take Action! six-episode podcast series features interviews with world-renowned experts in NAFLD, NASH and metabolic syndrome providing practical information for health care professionals on screening, diagnosing and managing these conditions. Collect up to 6 AMA PRA Category 1 credits for this activity by visiting nash.gastro.org.

Trailer: NASH: Take Action!

Welcome to Inside Scope, the American Gastroenterological Association podcast that will help you advance your patient care, one half-hour segment at a time. Join us to hear from the experts, learn new skills, and stay abreast of changing best practices in gastroenterology patient care.

Share Inside Scope

Sign up to save your podcasts

Inside Scope

Inside Scope episodes

About Inside Scope

More shows like Inside Scope

NEJM This Week

NEJM Interviews

JAMA Clinical Reviews

American Journal of Gastroenterology Author Podcasts

White Coat Investor Podcast

The Curbsiders Internal Medicine Podcast

JAMA Internal Medicine Author Interviews

Core IM | Internal Medicine Podcast

JAMAevidence The Rational Clinical Examination

JAMA Medical News

SmartLess